Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Clinical trial NCT00047255 · COMPLETED
Trial details
- NCT number
- NCT00047255
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2006-01-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.